Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice.
The mechanism of cooperation between IL-5 and eotaxin for the selective accumulation of eosinophils at sites of allergic inflammation is unknown. In this investigation we have used IL-5 deficient mice to define the relationship between this cytokine and eotaxin in the regulation of blood eosinophilia and eosinophil homing and tissue accumulation. Both IL-5 and eotaxin could independently induce a rapid and pronounced blood eosinophilia in wild type mice when administered systemically. In contrast, only eotaxin induced a pronounced blood eosinophilia in IL-5 deficient mice. The eosinophilic response induced by intravenous eotaxin in wild type mice did not correlate with a significant reduction in the level of bone marrow eosinophils, whereas intravenous IL-5 resulted in depletion of this store. These results suggest the existence of two mechanisms by which eosinophils can be rapidly mobilized in response to intravenous eosinophil chemoattractants; first, mobilization of an IL-5 dependent bone marrow pool, and second, an eotaxin-induced sequestration of eosinophils from tissues into the blood. Subcutaneous injection of eotaxin induced a local tissue eosinophilia in wild type mice but not in IL-5 deficient mice. Furthermore, tissue eosinophilia in wild type mice, but not in IL-5 deficient mice, was enhanced by adoptive transfer of eosinophils or the administration of intravenous IL-5. However, pretreatment of IL-5 deficient mice with intraperitoneal IL-5 for 72 h restored eosinophil homing and tissue accumulation in response to subcutaneous eotaxin. We propose that eotaxin secreted from inflamed tissue may play an important role in initiating both blood and tissue eosinophilia in the early phases of allergic inflammation. Furthermore, IL-5 is not only essential for mobilizing eosinophils from the bone marrow during allergic inflammation, but also plays a critical role in regulating eosinophil homing and migration into tissues in response to eotaxin and possibly other specific chemotactic stimuli.
Mould
A W
AW
Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Canberra.
Matthaei
K I
KI
Young
I G
IG
Foster
P S
PS
D019264:Adoptive Transfer; D000818:Animals; D001681:Biological Assay; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D054413:Chemokine CCL11; D019742:Chemokines, CC; D002633:Chemotaxis / Q000276:immunology / Q000502:physiology*; D016207:Cytokines / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology*; D004802:Eosinophilia / Q000235:genetics / Q000276:immunology* / Q000473:pathology; D004804:Eosinophils / Q000276:immunology; D006967:Hypersensitivity / Q000276:immunology* / Q000473:pathology; D007249:Inflammation / Q000473:pathology; D015848:Interleukin-5 / Q000008:administration & dosage / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008817:Mice, Mutant Strains; D012867:Skin / Q000187:drug effects / Q000276:immunology / Q000473:pathology
C515457:Ccl11 protein, mouse; D054413:Chemokine CCL11; D019742:Chemokines, CC; D016207:Cytokines; D015848:Interleukin-5